1. Home
  2. CLDX vs CXM Comparison

CLDX vs CXM Comparison

Compare CLDX & CXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • CXM
  • Stock Information
  • Founded
  • CLDX 1983
  • CXM 2009
  • Country
  • CLDX United States
  • CXM United States
  • Employees
  • CLDX N/A
  • CXM N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • CXM Computer Software: Prepackaged Software
  • Sector
  • CLDX Health Care
  • CXM Technology
  • Exchange
  • CLDX Nasdaq
  • CXM Nasdaq
  • Market Cap
  • CLDX 2.9B
  • CXM 1.8B
  • IPO Year
  • CLDX 2008
  • CXM 2021
  • Fundamental
  • Price
  • CLDX $28.74
  • CXM $7.22
  • Analyst Decision
  • CLDX Buy
  • CXM Hold
  • Analyst Count
  • CLDX 8
  • CXM 13
  • Target Price
  • CLDX $64.83
  • CXM $9.86
  • AVG Volume (30 Days)
  • CLDX 1.5M
  • CXM 1.6M
  • Earning Date
  • CLDX 10-31-2024
  • CXM 12-04-2024
  • Dividend Yield
  • CLDX N/A
  • CXM N/A
  • EPS Growth
  • CLDX N/A
  • CXM 566.50
  • EPS
  • CLDX N/A
  • CXM 0.17
  • Revenue
  • CLDX $8,303,000.00
  • CXM $773,698,000.00
  • Revenue This Year
  • CLDX N/A
  • CXM $8.44
  • Revenue Next Year
  • CLDX N/A
  • CXM $4.45
  • P/E Ratio
  • CLDX N/A
  • CXM $42.16
  • Revenue Growth
  • CLDX 155.16
  • CXM 14.72
  • 52 Week Low
  • CLDX $22.11
  • CXM $6.91
  • 52 Week High
  • CLDX $53.18
  • CXM $17.14
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 31.50
  • CXM 40.40
  • Support Level
  • CLDX $29.22
  • CXM $7.08
  • Resistance Level
  • CLDX $31.66
  • CXM $7.36
  • Average True Range (ATR)
  • CLDX 1.45
  • CXM 0.21
  • MACD
  • CLDX -0.17
  • CXM 0.05
  • Stochastic Oscillator
  • CLDX 5.57
  • CXM 32.63

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.

About CXM Sprinklr Inc.

Sprinklr Inc is engaged in providing enterprise software that enables every customer-facing function across the front office, from Customer Care to Marketing, to collaborate across internal silos, and communicate across digital channels. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights and Sprinklr Marketing. The company operates in Americas, EMEA and other countries. It derives maximum revenue from Americas.

Share on Social Networks: